Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWeight loss injections are expensive because they are complex prescription medicines that took billions in research investment to develop, must be manufactured under strict pharmaceutical conditions, and can only be legally supplied in the UK following a clinical assessment by a registered prescriber. Prices for the leading options currently range from roughly £149 to £375 per month in the private market, varying by dose and provider. That's a real cost, and it's worth understanding where it goes — because the number on the page rarely tells the whole story. These are prescription-only medicines, which means a prescriber must assess whether they are clinically suitable for you before any treatment can begin.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people searching this question have done the same thing: opened a private pharmacy website, seen a monthly figure that sits somewhere between a phone contract and a mortgage payment, and scrolled straight back to Google. The reaction is completely understandable. So let's start with the honest answer, which is that the price is high for several reasons, some of them legitimate, some of them worth scrutinising.
The medicines themselves, primarily tirzepatide (sold as Mounjaro) and semaglutide (sold as Wegovy), are among the most clinically significant treatments to reach the UK in a generation. The SURMOUNT-1 trial, involving over 2,500 adults, recorded average body-weight reductions of around 20–21% at the highest tirzepatide dose over 72 weeks, figures that compare favourably with surgical outcomes in some populations. The STEP 1 trial for semaglutide showed an average of around 15% weight reduction at 68 weeks. You can read the original SURMOUNT-1 paper in the New England Journal of Medicine if you want the full detail. That level of efficacy, achieved through a completely novel dual-hormone mechanism in tirzepatide's case, did not come cheap to develop.
Eli Lilly (Mounjaro's manufacturer) raised its UK list price significantly from 1 September 2025. The highest dose's list price moved from around £122 to around £330 per four-week pen, as widely reported that summer. Private providers now pay closer to that rate, and most have passed the increase on. Understanding the background of what weight loss injections cost in the UK helps make sense of that shift.
Here is where the price conversation gets more complicated. Not every listing charging less than the market rate is doing so because they have found a clever supply-chain shortcut. Some are, frankly, a risk.
The MHRA has issued repeated warnings about counterfeit weight loss pens being sold online, including fake pens found to contain insulin rather than the labelled medicine. Enforcement action in October 2025 included the first raid on an illicit UK manufacturing site producing counterfeit tirzepatide pens. Around 20 million doses of illegally traded weight loss medicines, with an estimated street value of £45 million, were seized in 2025 alone. The MHRA's Yellow Card scheme accepts reports of suspect sellers, and the regulator recommends buying only from a pharmacy you can verify on the GPhC register.
A low price can also signal something less dramatic but still problematic: a consultation that exists on paper but isn't genuinely reviewed by a clinician, no real prescriber oversight on dose increases, and no aftercare when things feel wrong. The prescription element of the cost is not an administrative nuisance. It is the clinical check that makes the medicine appropriate for you specifically, and if that check isn't happening properly, the saving isn't a saving at all. If you're asking why access to these medicines can be difficult, genuine clinical scrutiny is part of the answer.
Worth checking: any online pharmacy operating legally in the UK must be registered with the GPhC. You can verify one at the GPhC pharmacy register before handing over a prescription or payment.
Suppose you're comparing two monthly costs and one is notably lower. Before concluding it's a better deal, it is worth asking what is not in that number. Some providers charge separately for the consultation, the prescription, the delivery, and any follow-up support. Add those together and the advertised headline figure can climb considerably.
A full-service private provider folds all of those elements into a single price: the clinical consultation, the prescriber's review, the prescription, the medicine itself, delivery, and ongoing support if you have questions or concerns. If you're still getting to grips with what the weight loss injections actually are, understanding what you're paying for becomes much easier once you know what the treatment involves. The question is not whether the service costs more, but whether the alternative actually costs less once you add everything up.
There is also the question of what happens when things are not straightforward. If your dose needs adjusting, if you experience a side effect that needs clinical input, or if your progress stalls and you're wondering whether the injections are working as expected, a service with real prescriber oversight handles that differently from one that does not. The NHS England guidance on weight management injections makes clear that appropriate clinical wrap-around care is considered part of safe treatment, not an optional extra.
At nume, our prescribers are GPhC-registered Independent Prescribers who personally read every consultation. The clinical team behind that review is led by people like our lead prescriber, whose background and credentials are on the site for anyone to check. We are not the cheapest provider in the market, and we chose that deliberately, because the margin that gets cut first when a price drops is usually the clinical oversight. If you'd like a clear overview of the three weight loss injections available in the UK before deciding whether treatment is right for you, that page is a good place to start, and you can then begin your free consultation on our weight loss treatments page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.